RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustionApril 24, 2024 - " TILs and their subtypes can be used in gastric cancers (GC) for predictive and prognostic purposes. The complex interplay of TILs with factors like MMR, HER2, and H. pylori infection demonstrates that they form an integral part of the immune response to the tumor cells."
"In conclusion, TILs represent a promising avenue in the battle against GC. It is incumbent upon the medical and scientific communities to come together and realize the full potential of TILs, ensuring that their immense promise becomes a reality for all those affected by this devastating disease and other malignancies. "
https://www.wjgnet.com/2218-4333/full/v15/i4/478.htm
March 26, 2024 - The tumor-infiltrating CD161+CD8+ T cell is a valuable and promising predictor for survival and therapeutic response to adjuvant chemotherapy in PDAC.
https://pubmed.ncbi.nlm.nih.gov/38531664/